Point72 Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Point72 Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,100	Closed	-$1.57M	–	1242
2020 Q3	$1.57M	Sell	14,100 -1,600	-10%	-$172K	0.01%	731
2020 Q2	$1.6M	Buy	+15,700	New	+$1.68M	0.01%	625
2020 Q1	–	Sell	-5,731	Closed	-$667K	–	1227
2019 Q4	$667K	Sell	5,731 -12,320	-68%	-$1.43M	﹤0.01%	760
2019 Q3	$2.07M	Sell	18,051 -49,915	-73%	-$4.96M	0.01%	585
2019 Q2	$6.48M	Buy	+67,966	New	+$6.4M	0.03%	459
2018 Q3	–	Sell	-12,900	Closed	-$1.28M	–	1351
2018 Q2	$1.28M	Buy	+12,900	New	+$1.11M	0.01%	812
2017 Q1	–	Sell	-22,500	Closed	-$2.42M	–	1044
2016 Q4	$2.42M	Sell	22,500 -25,700	-53%	-$3M	0.02%	539
2016 Q3	$6M	Buy	48,200 +17,100	+55%	+$2.02M	0.04%	384
2016 Q2	$3.31M	Buy	+31,100	New	+$3.61M	0.02%	498
2015 Q3	–	Sell	-53,400	Closed	-$6.15M	–	976
2015 Q2	$6.15M	Buy	+53,400	New	+$5.61M	0.04%	414
2014 Q3	–	Sell	-8,000	Closed	-$356K	–	837
2014 Q2	$356K	Buy	+8,000	New	+$327K	﹤0.01%	651

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Point72 Asset Management's CBPO Position: Q4 2020 in Review

Point72 Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 14,100 shares — an estimated $1.57M sold.

Point72 Asset Management first reported a position in CBPO in Q2 2014 and held it in 11 quarters. The position peaked at $6.48M in Q2 2019. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Point72 Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Point72 Asset Management sold 14,100 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $1.57M.
Point72 Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 11 quarters.
Point72 Asset Management's China Biologic Products Holdings, Inc. position peaked at $6.48M in Q2 2019.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Point72 Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.